Medication use in adolescents treated in a French psychiatric setting for acute manic or mixed episode

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 18, Issue 3, 2009, Pages 231-238

  Consoli, Angèle ^a,b   Brunelle, Julie ^a,b   Bodeau, Nicolas ^a   Périsse, Didier ^a   Deniau, Emmanuelle ^a   Guilé, Jean Marc ^b,c   Cohen, David ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adolescence; Bipolar disorder; Pharmacological treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; VALPROMIDE;

ADOLESCENT; ADULT; AGRANULOCYTOSIS; ARTICLE; BRIEF PSYCHOTIC DISORDER; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MANIA; MEDICAL RECORD; MENTAL DEFICIENCY; MENTAL PERFORMANCE; MIXED MANIA AND DEPRESSION; NAUSEA; RETROSPECTIVE STUDY; SCHIZOPHRENIFORM DISORDER; SCHOOL CHILD; THROMBOCYTOPENIA; THYROID DISEASE; VOMITING;

EID: 70349179437     PISSN: 17198429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bauer, M. S. & Mitchner, L. (2004). What is a "mood stabilizer"? An evidence-based response, American Journal of Psychiatry, 161(1), 3-18.
2. Bhangoo, R. K., et al. (2003). Medication use in children and adolescents treated in the community for bipolar disorder, Journal of Child and Adolescent Psychopharmacology, 13(4), 515-22.
3. Bloch, Y., et al. (2001). Electroconvulsive therapy in adolescents: similarities to and differences from adults, Journal of the American Academy of Child and Adolescent Psychiatry, 40(11), 1332-6.
4. Bowden, C. L. (2001). Clinical correlates of therapeutic response in bipolar disorder, Journal of Affect Disorders, 67(1-3), 257-65.
5. Brunelle, J., et al. (2009). Phenomenology, socio-demographic factors and outcome upon discharge of manic and mixed episodes in hospitalized adolescents: A chart review, European Child and Adolescent Psychiatry.
6. Carlson, G. A. (2005). Where are the bipolar offspring? Journal of the American Academy of Child and Adolescent Psychiatry, 44(11), 1111-5; author reply 15-7.
7. Carlson, G. A., Fennig, S., & Bromet, E. J. (1994). The confusion between bipolar disorder and schizophrenia in youth: where does it stand in the 1990s? Journal of the American Academy of Child and Adolescent Psychiatry, 33(4), 453-60.
8. Carlson, G. A., et al. (2003). Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference, Journal of Child and Adolescent Psychopharmacology, 13(1), 13-27.
9. Case, B. G., et al. (2007). Trends in the inpatient mental health treatment of children and adolescents in US community hospitals between 1990 and 2000, Archives of General Psychiatry, 64(1), 89-96.
10. Cohen, D. (2007). Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned? Psychotherapy and Psychosomatics, 76(1), 5-14.
11. Cohen, D., Paillere-Martinot, M. L., & Basquin, M. (1997). Use of electroconvulsive therapy in adolescents, Convulsive Therapy, 13(1), 25-31.
12. Cohen, D., et al. (2008). Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials, PLoS ONE, 3(7), e2632.
13. Consoli, A., et al. (2007). Treatments in child and adolescent bipolar disorders, European Child and Adolescent Psychiatry, 16(3), 187-98.
14. Dailey, L. F., et al. (2005). Recidivism in medication-noncompliant serious juvenile offenders with bipolar disorder, Journal of Clinical Psychiatry, 66(4), 477-84.
15. Delbello, M. P., et al. (2002). A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania, Journal of the American Academy of Child and Adolescent Psychiatry, 41(10), 1216-23.
16. DelBello, M. P., et al. (2007). A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder, Journal of Clinical Psychiatry, 68(5), 789-95.
17. Delbello, M. P., et al. (2005). A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder, Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 539-47.
18. Delbello, M. M. et al. (2008). Research on the Effectiveness of Risperidone in Bipolar Disorder in Adolescents and Children (REACH): A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Risperidone forthe Treatment of Acute Mania in Bipolar I Disorder http://download.veritasmedicine.com/PDF/CR003631_CSR.pdf
19. Endicott, J., Spitzer, R. L., & Fleiss, J. (1976). GAF (Global Assessment of Functionning scale).
20. Fountoulakis, K. N., et al. (2007). Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder, Annuls of General Psychiatry, 6, 27.
21. Geller, B. & Luby, J. (1997). Child and adolescent bipolar disorder: a review of the past 10 years, Journal of the American Academy of Child and Adolescent Psychiatry, 36(9), 1168-76.
22. Geller, B., et al. (1998). Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency, Journal of the American Academy of Child and Adolescent Psychiatry, 37(2), 171-8.
23. Guy, W. (1970). CGI (Clinical Global Impressions), in Bonat RR Guy W, eds (ed.), Manual for the ECDEU Assesment Battery. 2. (National Institute of Mental Health).
24. Hagino, O. R., et al. (1995). Untoward effects of lithium treatment in children aged four through six years, Journal of the American Academy of Child and Adolescent Psychiatry, 34(12), 1584-90.
25. Harrington, R. & Myatt, T. (2003). Is preadolescent mania the same condition as adult mania? A British perspective, Biological Psychiatry, 53(11), 961-9.
26. Kafantaris, V., et al. (2004). Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study, Journal of the American Academy of Child and Adolescent Psychiatry, 43(8), 984-93.
27. Kim-Cohen, J., et al. (2003). Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort, Archives of General Psychiatry, 60(7), 709-17.
28. Kowatch, R. A. & DelBello, M. P. (2003). The use of mood stabilizers and atypical antipsychotics in children and adolescents with bipolar disorders, CNS Spectr, 8(4), 273-80.
29. Kowatch, R. A. & DelBello, M. P. (2005). Pharmacotherapy of children and adolescents with bipolar disorder, Psychiatric Clinics of North America, 28(2), 385-97.
30. Kowatch, R. A., et al. (2005). Treatment guidelines for children and adolescents with bipolar disorder, Journal of the American Academy of Child and Adolescent Psychiatry, 44(3), 213-35.
31. Kutcher, S. P. & Robertson, H. A. (1995). Electroconvulsive therapy in treatment-resistant bipolar youth, Journal of Child and Adolescent Psychopharmacology, 5, 167-75.
32. Lewinsohn, P. M., Klein, D. N., & Seeley, J. R. (1995). Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course, Journal of the American Academy of Child and Adolescent Psychiatry, 34(4), 454-63.
33. Luckasson, R., Borthwick-Duffy, S., & Buntix, W. (2002). Mental Retardation: definition, classification, and systems of supports (10th ed) (Washington, DC).
34. Marcelli, D. & Cohen, D. (2009). Enfance et psychopathologie (Paris: Masson).
35. McClellan, J. (2005). Commentary: treatment guidelines for child and adolescent bipolar disorder, Journal of the American Academy of Child and Adolescent Psychiatry, 44(3), 236-9.
36. Mueller, C. & Orvaschel, H. (1997). The failure of 'adult' interventions with adolescent depression: what does it mean for theory, research and practice? Journal of Affect Disorders, 44(2-3), 203-15.
37. Nurnberger, J. I., Jr., et al. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative, Archives of General Psychiatry, 51(11), 849-59; discussion 63-4.
38. Pande, A. C., et al. (2000). Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group, Bipolar Disorders, 2(3 Pt 2), 249-55.
39. Pavuluri, M. N., Birmaher, B., & Naylor, M. W. (2005). Pediatric bipolar disorder: a review of the past 10 years, Journal of the American Academy of Child and Adolescent Psychiatry, 44(9), 846-71.
40. Reed, C., et al. (2009). Observational study designs for bipolar disorder- what can they tell us about treatment in acute mania? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 715-721.
41. Ryan, N. D., Bhatara, V. S., & Perel, J. M. (1999). Mood stabilizers in children and adolescents, Journal of the American Academy of Child and Adolescent Psychiatry, 38(5), 529-36.
42. Sevilla-Dedieu, C. & Kovess-Masfety, V. (2008). Psychotropic medication use in children and adolescents: a study from France, Journal of Child and Adolescent Psychopharmacology, 18(3), 281-9.
43. Strober, M., et al. (1995). Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up, Journal of the American Academy of Child and Adolescent Psychiatry, 34(6), 724-31.
44. Tohen, M., et al. (2007). Olanzapine versus placebo in the treatment of adolescents with bipolar mania, American Journal of Psychiatry, 164(10), 1547-56.
45. Wagner, K. D., et al. (2006). A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents, American Journal of Psychiatry, 163(7), 1179-86.
46. Woods, S. W., et al. (2002). Effects of development on olanzapine-associated adverse events, Journal of the American Academy of Child and Adolescent Psychiatry, 41(12), 1439-46.
47. Young, R. C., et al. (1978). A rating scale for mania: reliability, validity and sensitivity, British Journal of Psychiatry, 133, 429-35.
48. Zhang, Y. (2008). Cost-saving effects of olanzapine as long-term treatment for bipolar disorder, Journal of Mental Health Policy and Economics, 11(3), 135-46.